DECR2 and posterior cortical atrophy: Further, high DECR2 levels were significantly associated with overall survival (p = 0.0233; Fig. 5c) in the SU2C clinical PCa cohort, consisting of patients with metastatic CRPC linked to longitudinal fatal outcomes [29].